Potent and Selective TYK2 degraders, Devoid of JAK Activity, Potently and Completely Suppress IL12/23 and Type I IFN Signaling Pathways

March 8, 2024

Potent and Selective TYK2 degraders, Devoid of JAK Activity, Potently and Completely Suppress IL12/23 and Type I IFN Signaling Pathways

American Academy of Dermatology (AAD) 2024 Annual Meeting

Isaac Marx, Amy Wang, Alex Wilkinson, Fergus Byrne, Andreas Harsch, Kan-Nian Hu, Anand Ramanathan, Guang Liu, Guoqiang Fang, Annan Yang, Rahul Karnik, Ei-Wen Yang, Nello Mainolfi, Matt Weiss, Anthony Slavin

Kymera TYK2 Poster Photo
Area of Focus
Immunology
Programs
TYK2 (KT-294)
Development Stage
Pre-clinical Data
Share
LinkedInXFacebookEmailCopy Link